Nonalcoholic fatty liver disease: lifestyle and quality of life View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-12-01

AUTHORS

Ilias Vachliotis, Antonis Goulas, Paraskevi Papaioannidou, Stergios A. Polyzos

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder whose current rapidly expanding prevalence is causing it to develop into a major global health concern. NAFLD is closely linked to the modern, unhealthy lifestyle. The Western diet, characterized by excessive energy intake, frequent consumption of red meat, processed meat and foods, soft drinks, and sugar-sweetened beverages (SSBs), irregular meal distribution throughout the day, and unhealthy ways of cooking, predisposes to development of NAFLD. Low levels of physical activity and prolonged sedentary time are additional lifestyle risk factors for NAFLD. Given the present lack of effective pharmacological treatment, lifestyle modifications are regarded as the cornerstone of NAFLD management. Reducing daily calorie intake together with following the Mediterranean diet (MD) is an increasingly accepted approach. Furthermore, increasing the level of physical activity and limiting sedentary behavior are additional measures proposed to improve the outcomes of the disease. Apart from being affected by lifestyle, NAFLD may also affect patients’ quality of life (QoL), mostly in the domain of physical function. In this regard, while the early and more benign form of the disease, i.e., simple hepatic steatosis, may not affect QoL, there is evidence, though conflicting, of the impact of nonalcoholic steatohepatitis (NASH) on this index, with, however, most studies showing that QoL is consistently affected in advanced disease, i.e., hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. Considering all the above, appropriate management of lifestyle is likely to attenuate the severity of the disease and improve the QoL of NAFLD patients. More... »

PAGES

41-49

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s42000-021-00339-6

DOI

http://dx.doi.org/10.1007/s42000-021-00339-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1143530072

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34854066


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Energy Intake", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Life Style", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Cirrhosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Non-alcoholic Fatty Liver Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece", 
          "id": "http://www.grid.ac/institutes/grid.4793.9", 
          "name": [
            "80th Battalion of Medical Corps, General Ioannis Makrygiannis Camp, Pyli, Kos, Greece", 
            "First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vachliotis", 
        "givenName": "Ilias", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece", 
          "id": "http://www.grid.ac/institutes/grid.4793.9", 
          "name": [
            "First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goulas", 
        "givenName": "Antonis", 
        "id": "sg:person.014754376524.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014754376524.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece", 
          "id": "http://www.grid.ac/institutes/grid.4793.9", 
          "name": [
            "First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Papaioannidou", 
        "givenName": "Paraskevi", 
        "id": "sg:person.015615620427.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015615620427.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece", 
          "id": "http://www.grid.ac/institutes/grid.4793.9", 
          "name": [
            "First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Polyzos", 
        "givenName": "Stergios A.", 
        "id": "sg:person.0720405206.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720405206.87"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00394-018-1711-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103973733", 
          "https://doi.org/10.1007/s00394-018-1711-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ejcn.2012.220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025016687", 
          "https://doi.org/10.1038/ejcn.2012.220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40200-019-00475-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1124936667", 
          "https://doi.org/10.1007/s40200-019-00475-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12876-020-01204-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1125615597", 
          "https://doi.org/10.1186/s12876-020-01204-3"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-12-01", 
    "datePublishedReg": "2021-12-01", 
    "description": "Abstract\nNonalcoholic fatty liver disease (NAFLD) is a metabolic disorder whose current rapidly expanding prevalence is causing it to develop into a major global health concern. NAFLD is closely linked to the modern, unhealthy lifestyle. The Western diet, characterized by excessive energy intake, frequent consumption of red meat, processed meat and foods, soft drinks, and sugar-sweetened beverages (SSBs), irregular meal distribution throughout the day, and unhealthy ways of cooking, predisposes to development of NAFLD. Low levels of physical activity and prolonged sedentary time are additional lifestyle risk factors for NAFLD. Given the present lack of effective pharmacological treatment, lifestyle modifications are regarded as the cornerstone of NAFLD management. Reducing daily calorie intake together with following the Mediterranean diet (MD) is an increasingly accepted approach. Furthermore, increasing the level of physical activity and limiting sedentary behavior are additional measures proposed to improve the outcomes of the disease. Apart from being affected by lifestyle, NAFLD may also affect patients\u2019 quality of life (QoL), mostly in the domain of physical function. In this regard, while the early and more benign form of the disease, i.e., simple hepatic steatosis, may not affect QoL, there is evidence, though conflicting, of the impact of nonalcoholic steatohepatitis (NASH) on this index, with, however, most studies showing that QoL is consistently affected in advanced disease, i.e., hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. Considering all the above, appropriate management of lifestyle is likely to attenuate the severity of the disease and improve the QoL of NAFLD patients.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s42000-021-00339-6", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1030758", 
        "issn": [
          "1109-3099", 
          "2520-8721"
        ], 
        "name": "Hormones", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "keywords": [
      "nonalcoholic fatty liver disease", 
      "sugar-sweetened beverages", 
      "quality of life", 
      "nonalcoholic steatohepatitis", 
      "physical activity", 
      "Mediterranean diet", 
      "development of NAFLD", 
      "major global health concern", 
      "simple hepatic steatosis", 
      "lifestyle risk factors", 
      "fatty liver disease", 
      "effective pharmacological treatment", 
      "excessive energy intake", 
      "global health concern", 
      "lifestyle modification", 
      "advanced disease", 
      "NAFLD patients", 
      "NAFLD management", 
      "liver disease", 
      "pharmacological treatment", 
      "physical function", 
      "hepatic steatosis", 
      "hepatic fibrosis", 
      "risk factors", 
      "Western diet", 
      "sedentary time", 
      "unhealthy lifestyle", 
      "hepatocellular carcinoma", 
      "sedentary behavior", 
      "metabolic disorders", 
      "daily calories", 
      "frequent consumption", 
      "meal distribution", 
      "appropriate management", 
      "energy intake", 
      "health concern", 
      "benign form", 
      "disease", 
      "red meat", 
      "QoL", 
      "patients", 
      "soft drinks", 
      "lifestyle", 
      "diet", 
      "most studies", 
      "low levels", 
      "additional measures", 
      "unhealthy ways", 
      "cirrhosis", 
      "steatohepatitis", 
      "steatosis", 
      "carcinoma", 
      "fibrosis", 
      "prevalence", 
      "intake", 
      "severity", 
      "disorders", 
      "calories", 
      "outcomes", 
      "management", 
      "levels", 
      "treatment", 
      "activity", 
      "life", 
      "drinks", 
      "meat", 
      "days", 
      "beverages", 
      "cornerstone", 
      "evidence", 
      "food", 
      "index", 
      "factors", 
      "present lack", 
      "quality", 
      "study", 
      "measures", 
      "lack", 
      "regard", 
      "concern", 
      "function", 
      "development", 
      "consumption", 
      "time", 
      "impact", 
      "cooking", 
      "modification", 
      "form", 
      "approach", 
      "domain", 
      "distribution", 
      "behavior", 
      "way"
    ], 
    "name": "Nonalcoholic fatty liver disease: lifestyle and quality of life", 
    "pagination": "41-49", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1143530072"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s42000-021-00339-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34854066"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s42000-021-00339-6", 
      "https://app.dimensions.ai/details/publication/pub.1143530072"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_876.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s42000-021-00339-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00339-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00339-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00339-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s42000-021-00339-6'


 

This table displays all metadata directly associated to this object as RDF triples.

220 TRIPLES      22 PREDICATES      130 URIs      118 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s42000-021-00339-6 schema:about N0e1d4dbe63ce4c8991df5d743ad47253
2 N1856b2210d5a47f5b9908b2609931ada
3 N3d112398b287413f9fcd7139871cd1c7
4 N4e14f35d345b4b19ac50ad7a819e51cf
5 N9e29d2c367ee4f57a81873daca9c55b3
6 Nb703ff8f8508448aa9c645c278451707
7 Nda97e32da0dc440696aa36006df8f5fe
8 anzsrc-for:11
9 anzsrc-for:1103
10 schema:author Nd7385133389943c88596e69dcf7a3f59
11 schema:citation sg:pub.10.1007/s00394-018-1711-4
12 sg:pub.10.1007/s40200-019-00475-2
13 sg:pub.10.1038/ejcn.2012.220
14 sg:pub.10.1186/s12876-020-01204-3
15 schema:datePublished 2021-12-01
16 schema:datePublishedReg 2021-12-01
17 schema:description Abstract Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder whose current rapidly expanding prevalence is causing it to develop into a major global health concern. NAFLD is closely linked to the modern, unhealthy lifestyle. The Western diet, characterized by excessive energy intake, frequent consumption of red meat, processed meat and foods, soft drinks, and sugar-sweetened beverages (SSBs), irregular meal distribution throughout the day, and unhealthy ways of cooking, predisposes to development of NAFLD. Low levels of physical activity and prolonged sedentary time are additional lifestyle risk factors for NAFLD. Given the present lack of effective pharmacological treatment, lifestyle modifications are regarded as the cornerstone of NAFLD management. Reducing daily calorie intake together with following the Mediterranean diet (MD) is an increasingly accepted approach. Furthermore, increasing the level of physical activity and limiting sedentary behavior are additional measures proposed to improve the outcomes of the disease. Apart from being affected by lifestyle, NAFLD may also affect patients’ quality of life (QoL), mostly in the domain of physical function. In this regard, while the early and more benign form of the disease, i.e., simple hepatic steatosis, may not affect QoL, there is evidence, though conflicting, of the impact of nonalcoholic steatohepatitis (NASH) on this index, with, however, most studies showing that QoL is consistently affected in advanced disease, i.e., hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. Considering all the above, appropriate management of lifestyle is likely to attenuate the severity of the disease and improve the QoL of NAFLD patients.
18 schema:genre article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf N17384904b3b5464e984748bbea2cae49
22 Naa00bbdf879b47cda91eb0668190bf5d
23 sg:journal.1030758
24 schema:keywords Mediterranean diet
25 NAFLD management
26 NAFLD patients
27 QoL
28 Western diet
29 activity
30 additional measures
31 advanced disease
32 approach
33 appropriate management
34 behavior
35 benign form
36 beverages
37 calories
38 carcinoma
39 cirrhosis
40 concern
41 consumption
42 cooking
43 cornerstone
44 daily calories
45 days
46 development
47 development of NAFLD
48 diet
49 disease
50 disorders
51 distribution
52 domain
53 drinks
54 effective pharmacological treatment
55 energy intake
56 evidence
57 excessive energy intake
58 factors
59 fatty liver disease
60 fibrosis
61 food
62 form
63 frequent consumption
64 function
65 global health concern
66 health concern
67 hepatic fibrosis
68 hepatic steatosis
69 hepatocellular carcinoma
70 impact
71 index
72 intake
73 lack
74 levels
75 life
76 lifestyle
77 lifestyle modification
78 lifestyle risk factors
79 liver disease
80 low levels
81 major global health concern
82 management
83 meal distribution
84 measures
85 meat
86 metabolic disorders
87 modification
88 most studies
89 nonalcoholic fatty liver disease
90 nonalcoholic steatohepatitis
91 outcomes
92 patients
93 pharmacological treatment
94 physical activity
95 physical function
96 present lack
97 prevalence
98 quality
99 quality of life
100 red meat
101 regard
102 risk factors
103 sedentary behavior
104 sedentary time
105 severity
106 simple hepatic steatosis
107 soft drinks
108 steatohepatitis
109 steatosis
110 study
111 sugar-sweetened beverages
112 time
113 treatment
114 unhealthy lifestyle
115 unhealthy ways
116 way
117 schema:name Nonalcoholic fatty liver disease: lifestyle and quality of life
118 schema:pagination 41-49
119 schema:productId N17a3ccac6f4149a382918cb64bb6263b
120 N830be12374c2412cbc38cb21b619849f
121 N8e955669582c46d38afae0e780283683
122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1143530072
123 https://doi.org/10.1007/s42000-021-00339-6
124 schema:sdDatePublished 2022-05-20T07:38
125 schema:sdLicense https://scigraph.springernature.com/explorer/license/
126 schema:sdPublisher N9e5a1ae035d94ad9832a5056dcb5d74d
127 schema:url https://doi.org/10.1007/s42000-021-00339-6
128 sgo:license sg:explorer/license/
129 sgo:sdDataset articles
130 rdf:type schema:ScholarlyArticle
131 N0e1d4dbe63ce4c8991df5d743ad47253 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Liver Cirrhosis
133 rdf:type schema:DefinedTerm
134 N17384904b3b5464e984748bbea2cae49 schema:issueNumber 1
135 rdf:type schema:PublicationIssue
136 N17a3ccac6f4149a382918cb64bb6263b schema:name dimensions_id
137 schema:value pub.1143530072
138 rdf:type schema:PropertyValue
139 N1856b2210d5a47f5b9908b2609931ada schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Non-alcoholic Fatty Liver Disease
141 rdf:type schema:DefinedTerm
142 N206d652d0106462b9113b8534c7fbe78 schema:affiliation grid-institutes:grid.4793.9
143 schema:familyName Vachliotis
144 schema:givenName Ilias
145 rdf:type schema:Person
146 N2f0f60a9374f4555b52c7cf61364a660 rdf:first sg:person.014754376524.89
147 rdf:rest N6cc88830398a4f7f9454af5f14f98951
148 N31da088e6d524305be90304fdf7c9fc5 rdf:first sg:person.0720405206.87
149 rdf:rest rdf:nil
150 N3d112398b287413f9fcd7139871cd1c7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Quality of Life
152 rdf:type schema:DefinedTerm
153 N4e14f35d345b4b19ac50ad7a819e51cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Liver
155 rdf:type schema:DefinedTerm
156 N6cc88830398a4f7f9454af5f14f98951 rdf:first sg:person.015615620427.20
157 rdf:rest N31da088e6d524305be90304fdf7c9fc5
158 N830be12374c2412cbc38cb21b619849f schema:name pubmed_id
159 schema:value 34854066
160 rdf:type schema:PropertyValue
161 N8e955669582c46d38afae0e780283683 schema:name doi
162 schema:value 10.1007/s42000-021-00339-6
163 rdf:type schema:PropertyValue
164 N9e29d2c367ee4f57a81873daca9c55b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Energy Intake
166 rdf:type schema:DefinedTerm
167 N9e5a1ae035d94ad9832a5056dcb5d74d schema:name Springer Nature - SN SciGraph project
168 rdf:type schema:Organization
169 Naa00bbdf879b47cda91eb0668190bf5d schema:volumeNumber 21
170 rdf:type schema:PublicationVolume
171 Nb703ff8f8508448aa9c645c278451707 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Humans
173 rdf:type schema:DefinedTerm
174 Nd7385133389943c88596e69dcf7a3f59 rdf:first N206d652d0106462b9113b8534c7fbe78
175 rdf:rest N2f0f60a9374f4555b52c7cf61364a660
176 Nda97e32da0dc440696aa36006df8f5fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Life Style
178 rdf:type schema:DefinedTerm
179 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
180 schema:name Medical and Health Sciences
181 rdf:type schema:DefinedTerm
182 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
183 schema:name Clinical Sciences
184 rdf:type schema:DefinedTerm
185 sg:journal.1030758 schema:issn 1109-3099
186 2520-8721
187 schema:name Hormones
188 schema:publisher Springer Nature
189 rdf:type schema:Periodical
190 sg:person.014754376524.89 schema:affiliation grid-institutes:grid.4793.9
191 schema:familyName Goulas
192 schema:givenName Antonis
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014754376524.89
194 rdf:type schema:Person
195 sg:person.015615620427.20 schema:affiliation grid-institutes:grid.4793.9
196 schema:familyName Papaioannidou
197 schema:givenName Paraskevi
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015615620427.20
199 rdf:type schema:Person
200 sg:person.0720405206.87 schema:affiliation grid-institutes:grid.4793.9
201 schema:familyName Polyzos
202 schema:givenName Stergios A.
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720405206.87
204 rdf:type schema:Person
205 sg:pub.10.1007/s00394-018-1711-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103973733
206 https://doi.org/10.1007/s00394-018-1711-4
207 rdf:type schema:CreativeWork
208 sg:pub.10.1007/s40200-019-00475-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1124936667
209 https://doi.org/10.1007/s40200-019-00475-2
210 rdf:type schema:CreativeWork
211 sg:pub.10.1038/ejcn.2012.220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025016687
212 https://doi.org/10.1038/ejcn.2012.220
213 rdf:type schema:CreativeWork
214 sg:pub.10.1186/s12876-020-01204-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1125615597
215 https://doi.org/10.1186/s12876-020-01204-3
216 rdf:type schema:CreativeWork
217 grid-institutes:grid.4793.9 schema:alternateName First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
218 schema:name 80th Battalion of Medical Corps, General Ioannis Makrygiannis Camp, Pyli, Kos, Greece
219 First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
220 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...